Patrick T McGann (Patrick McGann)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Topics

Sickle Cell Disease

Plasmodium Falciparum

Chronic Kidney Disease

Top Venues

American journal of hematology

Pediatric blood & cancer

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Faiza Yasin, Patrick T McGann, Layla Van Doren
Hydroxyurea in pregnancy: Reframing the conversation. American journal of hematology (2024)
Faiza Yasin, Patrick T McGann, Layla Van Doren
Hydroxyurea in pregnancy: Reframing the conversation. American journal of hematology 99 (7) (2024)
Faiza Yasin, Patrick T McGann, Layla Van Doren
Hydroxyurea in pregnancy: Reframing the conversation. American journal of hematology 99 (7) (2024)
Daniel Dexter, Patrick T McGann
Hydroxyurea for Children with Sickle Cell Disease in sub-Saharan Africa: A Summary of the Evidence, Opportunities, and Challenges. Pharmacotherapy (2023)
Halimat S Olaniyan, Christine Briscoe, Margarida Muhongo, Rui Adelino Pascoal, António Armando, Brigida Santos, Patrick T McGann
Early Diagnosis of Sickle Cell Disease at Birth Hospitals and Vaccination Centers in Angola Using Point-of-Care Tests. Blood advances (2023)
Susan E Creary, Chase Beeman, Joseph R Stanek, Kathryn King, Patrick T McGann, Sarah H O'Brien, Robert I Liem, Jane Holl, Sherif M Badawy
Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatric blood & cancer 69 (6) (2022)
Kristine A Karkoska, Amanda Pfeiffer, Dean W Beebe, Charles T Quinn, Omar Niss, Patrick T McGann
Early hydroxyurea use is neuroprotective in children with sickle cell anemia. American journal of hematology 97 (10) (2022)
Patrick T McGann, Angela Christine Weyand
Lessons learned from the COVID-19 pandemic blood supply crisis. Journal of hospital medicine 17 (7) (2022)
Alexandra Power-Hays, Christopher E Dandoy, Angela Lorts, John P Perentesis, Ndidi Unaka, Russell E Ware, Patrick T McGann
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity. Pediatric blood & cancer 69 (8) (2022)
Natasha M Archer, Baba Inusa, Julie Makani, Siana Nkya, Léon Tshilolo, Venee N Tubman, Patrick T McGann, Emmanuela Eusebio Ambrose, Natalie Henrich, Jonathan Spector, Kwaku Ohene-Frempong
Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ open 12 (3) (2022)
Emily Vistica Sampino, Patrick T McGann
System's failure: Poor adherence to guidelines for children with sickle cell disease. Pediatric blood & cancer (2021)
Kristine A Karkoska, Kevin Edward Todd, Omar Niss, Kelly Clapp, Lynette Fenchel, Theodosia A Kalfa, Parul Rai, Charles T Quinn, Russell E Ware, Patrick T McGann
Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experience. Pediatric blood & cancer 68 (6) (2021)
Kristine A Karkoska, Charles T Quinn, Omar Niss, Amanda Pfeiffer, Min Dong, Alexander A Vinks, Patrick T McGann
Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia. American journal of hematology 96 (5) (2021)
Alexander A Boucher, Ashley Bedel, Sommer Jones, Stephanie F Lenahan, Rebecca Geer, Patrick T McGann
A retrospective study of the safety and efficacy of low molecular weight iron dextran for children with iron deficiency anemia. Pediatric blood & cancer 68 (7) (2021)
Kristine A Karkoska, Patrick T McGann
How I approach disease-modifying therapy in children with sickle cell disease in an era of novel therapies. Pediatric blood & cancer 68 (12) (2021)
Charles T Quinn, Omar Niss, Min Dong, Amanda Pfeiffer, Jennifer Korpik, Mary Reynaud, Holly Bonar, Theodosia A Kalfa, Luke R Smart, Punam Malik, Russell E Ware, Alexander A Vinks, Patrick T McGann
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. British journal of haematology 194 (3) (2021)
Daniel Dexter, Patrick T McGann
The promise and role of point of care testing to reduce the global burden of sickle cell disease through early diagnosis and linkage to care. British journal of haematology (2021)
Emily R Meier, Susan E Creary, Matthew M Heeney, Min Dong, Abena O Appiah-Kubi, Stephen C Nelson, Omar Niss, Connie Piccone, Maa-Ohui Quarmyne, Charles T Quinn, Kay L Saving, John P Scott, Ravi Talati, Teresa S Latham, Amanda Pfeiffer, Lisa M Shook, Alexander A Vinks, Adam Lane, Patrick T McGann
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia. Trials 21 (1) (2020)
Kristine A Karkoska, Charles T Quinn, Kelly Clapp, Patrick T McGann
Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease. American journal of hematology 95 (12) (2020)
Marina S Perez-Plazola, Erika A Tyburski, Luke R Smart, Thad A Howard, Amanda Pfeiffer, Russell E Ware, Wilbur A Lam, Patrick T McGann
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings. BMC medicine 18 (1) (2020)
Min Dong, Patrick T McGann
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine. Clinical pharmacology and therapeutics 109 (1) (2020)
Patrick T McGann, Anne M Williams, Graham Ellis, Kathryn E McElhinney, Laurel Romano, Julia Woodall, Thad A Howard, Gerald Tegha, Robert Krysiak, R Murray Lark, E Louise Ander, Carine Mapango, Kenneth I Ataga, Satish Gopal, Nigel S Key, Russell E Ware, Parminder S Suchdev
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children. Blood advances 2 (21) (2019)
Patrick T McGann, Omar Niss, Min Dong, Anu Marahatta, Thad A Howard, Tomoyuki Mizuno, Adam Lane, Theodosia A Kalfa, Punam Malik, Charles T Quinn, Russell E Ware, Alexander A Vinks
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia. American journal of hematology 94 (8) (2019)
Russell E Ware, Patrick T McGann, Charles T Quinn
Hydroxyurea for children with sickle cell anemia: Prescribe it early and often. Pediatric blood & cancer 66 (8) (2019)
Patrick T McGann, Thomas N Williams, Peter Olupot-Olupot, George A Tomlinson, Adam Lane, José Luís Reis da Fonseca, Robert Kitenge, George Mochamah, Ham Wabwire, Susan Stuber, Thad A Howard, Kathryn McElhinney, Banu Aygun, Teresa Latham, Brígida Santos, Mariane de Montalembert, Russell E Ware, null null
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa. American journal of hematology 93 (4) (2018)
Mariane de Montalembert, George A Tomlinson, Thomas N Williams, Brígida Santos, Peter Olupot-Olupot, Adam Lane, Banu Aygun, Susan E Stuber, Teresa S Latham, Patrick T McGann, Russell E Ware, null null
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa. The New England journal of medicine 380 (2) (2018)
Patrick T McGann, Arielle G Hernandez, Russell E Ware
Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood 129 (2) (2016)